| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |